Davion Healthcare Plc fell 16.0% on Friday, November 13, 2026, on 312,173 shares. No headline about DAVI came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Davion Healthcare Plc (DAVI:NASDAQ) closed at $1.00 on November 13, 2026, down 15.97% on the day. The stock trades 91.9% below its 52-week high of $12.30 and 9.3% above its 52-week low of $0.915. Over the past year, it lost 91.4%. Davion Healthcare Plc is part of the Health Care sector.
Davion Healthcare Plc is a next-generation digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion's broader portfolio includes technologies addressing circulation and foot health, testicular health, skin anomalies, wound monitoring, blood pressure and other areas of preventive healthcare. Davion's growth strategy combines the development and commercialisation of its proprietary technologies with complementary acquisitions intended to expand the Group's product portfolio and commercial, manufacturing and distribution capabilities.
Find more stocks like DAVI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.